Galderma Group AG (XSWX:GALD) Inventories, Inventories Adjustments: CHF0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:GALD Galderma Group AG XSWX:GALD
16 GF Score
Price CHF171.55
! 3 Warning Signs
View Full Analysis

What is Galderma Group AG Inventories, Inventories Adjustments?

Galderma Group AG XSWX:GALD +1.39% 16 Inventories, Inventories Adjustments is CHF0 Mil as of Jun. 2026. GuruFocus rates XSWX:GALD with a GF Score™ of 16/100. The stock has 3 warning signs investors should review.

Galderma Group AG's Inventories, Inventories Adjustments for the quarter that ended in Jun. 2026 was CHF0 Mil.

Galderma Group AG's quarterly Inventories, Inventories Adjustments declined from Jun. 2025 (CHF0 Mil) to Dec. 2025 (CHF-33 Mil) but then increased from Dec. 2025 (CHF-33 Mil) to Jun. 2026 (CHF0 Mil).

Galderma Group AG's annual Inventories, Inventories Adjustments declined from Dec. 2023 (CHF-29 Mil) to Dec. 2024 (CHF-35 Mil) but then increased from Dec. 2024 (CHF-35 Mil) to Dec. 2025 (CHF-33 Mil).

Galderma Group AG Inventories, Inventories Adjustments Historical Data

* Premium members only.

The historical data trend for Galderma Group AG's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG Inventories, Inventories Adjustments Chart

Galderma Group AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Inventories Adjustments
0.00 0.00 -29.40 -34.77 -33.47

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Inventories, Inventories Adjustments Get a 7-Day Free Trial 0.00 -34.77 0.00 -33.47 0.00
XSWX:GALD
16GF Score
Galderma Group AG XSWX:GALD
Inventories, Inventories Adjustments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galderma Group AG Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.

What does a Inventories, Inventories Adjustments of CHF0 Mil mean?
Galderma Group AG (XSWX:GALD) has a Inventories, Inventories Adjustments of CHF0 Mil as of Jun. 2026. Inventories, Inventories Adjustments is certain charges made in the current period in inventory resulting from breakage, spoilage, etc. View historical data on Galderma Group AG and its competitors.
Is Galderma Group AG's Inventories, Inventories Adjustments too high?
Galderma Group AG's current Inventories, Inventories Adjustments is CHF0 Mil. Overall, Galderma Group AG has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's Inventories, Inventories Adjustments compare to ZTS and UTHR?
Galderma Group AG's Inventories, Inventories Adjustments of CHF0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Inventories Adjustments for a Drug Manufacturers company?
A good Inventories, Inventories Adjustments depends on the Drug Manufacturers industry context. However, Inventories, Inventories Adjustments should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Inventories Adjustments mean?
A high Inventories, Inventories Adjustments can signal that a stock is expensive relative to its fundamentals. Inventories, Inventories Adjustments is certain charges made in the current period in inventory resulting from breakage, spoilage, etc. View historical data on Galderma Group AG and its competitors. Galderma Group AG's current Inventories, Inventories Adjustments is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (XSWX:GALD) has a current Inventories, Inventories Adjustments of CHF0 Mil. The current Inventories, Inventories Adjustments is CHF0 Mil. Galderma Group AG's overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Inventories Adjustments calculated?
Inventories, Inventories Adjustments is calculated from a company's financial statements. For Galderma Group AG (XSWX:GALD), the current Inventories, Inventories Adjustments is CHF0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galderma Group AG Business Description

Address Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
16GF Score

Get the complete analysis for XSWX:GALD

Inventories, Inventories Adjustments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF171.55
Price